NEWS June 11, 2025 Galux and HanAll Biopharma Initiate Strategic Collaboration to Develop AI-Designed Antibody Therapeutics for Cancer Read More
NEWS March 17, 2025 Galux Unveils a Study in AI-Powered De Novo Antibody Design for Multiple Therapeutic Targets Read More
NEWS September 19, 2024 Galux Unveils Breakthrough AI Technology for Therapeutic Antibody Loop Design Read More
NEWS August 26, 2024 Galux and LG Chem Initiate Joint Research on AI-Powered Cancer Drug Development Read More
